Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
Reports of cerebral venous sinus thrombosis and intracranial hemorrhage (ICH) following the administration of coronavirus vaccines have raised concerns regarding their safety. Although no regulatory authority has recognized ICH as an adverse event associated with tozinameran (BNT162b2, Pfizer-BioNTe...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Online Access: | http://dx.doi.org/10.1186/s40545-021-00326-7 |